Category Archives: Specialty Drug

Biologics Selected by Agios Pharmaceuticals as Exclusive Distributor of PYRUKYND®

PYRUKYND prescriptions are processed exclusively through Biologics by McKesson to give patients a seamless experience

Optum Specialty Fusion™ Launched To Streamline Care and Lower Costs

Optum Specialty Fusion™ was launched to streamline treatment decision-making for care providers, helping patients get on their therapies faster

Humana Specialty Pharmacy Adds Two Drugs to its Targeted Oncology Therapies

Humana Specialty Pharmacy’s Oncology Cancer Center of Excellence’s dedicated team of specialty pharmacists offer personalized outreach to help maximize the outcomes of cancer therapy

Magellan Rx and Zipline Partner to Deliver Specialty and Traditional Prescriptions

Magellan Rx and Zipline partner to deliver prescription medications, including specialty medications that treat chronic, complex conditions, directly to patients’ homes via autonomous aircraft

argenx SE Selects Soleo Health as a Limited Distribution Partner for VYVGART

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, recently announced it was selected as a limited distribution partner for VYVGART

Idorsia Ltd. Strengthens Commercialization Collaboration with Syneos Health

Idorsia Ltd. and Syneos Health® announced the extension of an existing collaboration to commercialize daridorexant, a novel dual orexin receptor antagonist for the treatment of insomnia across Europe and Canada

Recent Activities Position AscellaHealth As a Leader in Specialty Pharmaceutical Services

AscellaHealth recently announced a comprehensive suite of Specialty Pharmacy (SP) services, including pre-commercialization, outsourced market access, wholesale, 3PL, limited distribution drug (LDD) fulfillment, and custom Patient Support and HUB Services

Amber Specialty Pharmacy Selected by Takeda to Dispense LIVTENCITY™

Amber Specialty Pharmacy announced that it will begin dispensing LIVTENCITY™ (maribavir), the first and only treatment indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant CMV infection/disease